- Home
- OCEAW vs PRA Comparison
OCEAW vs PRA Comparison
Compare OCEAW & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEAW
- PRA
- Stock Information
- Founded
- OCEAW N/A
- PRA 1976
- Country
- OCEAW United States
- PRA United States
- Employees
- OCEAW 7
- PRA N/A
- Industry
- OCEAW Biotechnology: Pharmaceutical Preparations
- PRA Property-Casualty Insurers
- Sector
- OCEAW Health Care
- PRA Finance
- Exchange
- OCEAW Nasdaq
- PRA Nasdaq
- Market Cap
- OCEAW N/A
- PRA N/A
- IPO Year
- OCEAW 2021
- PRA N/A
- Fundamental
- Price
- OCEAW $0.03
- PRA $15.11
- Analyst Decision
- OCEAW
- PRA Buy
- Analyst Count
- OCEAW 0
- PRA 3
- Target Price
- OCEAW N/A
- PRA $19.33
- AVG Volume (30 Days)
- OCEAW N/A
- PRA 240.0K
- Earning Date
- OCEAW N/A
- PRA 05-05-2025
- Dividend Yield
- OCEAW N/A
- PRA N/A
- EPS Growth
- OCEAW N/A
- PRA N/A
- EPS
- OCEAW N/A
- PRA 1.03
- Revenue
- OCEAW N/A
- PRA $1,143,673,000.00
- Revenue This Year
- OCEAW N/A
- PRA N/A
- Revenue Next Year
- OCEAW N/A
- PRA $0.83
- P/E Ratio
- OCEAW N/A
- PRA $14.66
- Revenue Growth
- OCEAW N/A
- PRA 0.30
- 52 Week Low
- OCEAW N/A
- PRA $10.76
- 52 Week High
- OCEAW N/A
- PRA $17.79
- Technical
- Relative Strength Index (RSI)
- OCEAW N/A
- PRA 48.66
- Support Level
- OCEAW N/A
- PRA $14.86
- Resistance Level
- OCEAW N/A
- PRA $16.29
- Average True Range (ATR)
- OCEAW 0.00
- PRA 0.53
- MACD
- OCEAW 0.00
- PRA 0.02
- Stochastic Oscillator
- OCEAW 0.00
- PRA 42.61
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.